EADO/WCM 2025 | Integrating global data to inform melanoma treatment guidelines

Satoshi Fukushima • 3 Apr 2025

EADO/WCM 2025

Melanoma Skin Cancer

Satoshi Fukushima, MD, PhD, Kumamoto University, Kumamoto, Japan, comments on the need for regionalized guidelines in cancer treatment. Dr Fukushima notes that randomized controlled trials may not be feasible in all regions due to various factors, and therefore, incorporating data from Western countries and real-world data from their own region can help create more effective and tailored guidelines. This approach can better reflect the unique characteristics and challenges of each region, ultimately leading to improved patient outcomes. This interview took place at the 11th World Congress of Melanoma and 21st EADO Congress in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.